DJIA 15,294.50 -12.67 -0.08%
NASDAQ 3,459.42 -3.88 -0.11%
S&P 500 1,650.51 -4.84 -0.29%

Medivation, Inc.

NASDAQ: MDVN


company name or ticker

Medivation, Inc. Presents at UBS Global Healthcare Conference, May-20-2013 01:00 PM

Bayer's Xofigo Cleared in the US - Analyst Blog

The 8 Biggest Health Problems Americans Face

What health problems do Americans think are most significant? Some of the answers might be surprising.

Energy And Biotechs With Recent Earnings Catalysts

Medivation Loss Narrower Than Expected - Analyst Blog

Medivation Inc. Stock Downgraded (MDVN)

Dendreon: Picking Through the Carnage

First-quarter results for the prostate cancer drug maker were even uglier than anticipated.

3 Horrendous Health-Care Stocks This Week

These three health-care stocks were party-poopers this week as investors celebrated the market hitting all-time highs, yet again.

Medivation Inc. (MDVN): Today's Featured Drugs Laggard

Is Dendreon Done After Q1 Train Wreck?

See More Articles...